全文获取类型
收费全文 | 22121篇 |
免费 | 1605篇 |
国内免费 | 645篇 |
专业分类
耳鼻咽喉 | 132篇 |
儿科学 | 403篇 |
妇产科学 | 393篇 |
基础医学 | 1633篇 |
口腔科学 | 541篇 |
临床医学 | 3446篇 |
内科学 | 4016篇 |
皮肤病学 | 307篇 |
神经病学 | 1061篇 |
特种医学 | 481篇 |
外国民族医学 | 1篇 |
外科学 | 2339篇 |
综合类 | 2847篇 |
现状与发展 | 3篇 |
预防医学 | 997篇 |
眼科学 | 334篇 |
药学 | 4007篇 |
13篇 | |
中国医学 | 817篇 |
肿瘤学 | 600篇 |
出版年
2023年 | 367篇 |
2022年 | 656篇 |
2021年 | 958篇 |
2020年 | 831篇 |
2019年 | 704篇 |
2018年 | 649篇 |
2017年 | 668篇 |
2016年 | 663篇 |
2015年 | 734篇 |
2014年 | 1140篇 |
2013年 | 1478篇 |
2012年 | 1104篇 |
2011年 | 1238篇 |
2010年 | 1015篇 |
2009年 | 884篇 |
2008年 | 911篇 |
2007年 | 982篇 |
2006年 | 840篇 |
2005年 | 733篇 |
2004年 | 653篇 |
2003年 | 591篇 |
2002年 | 483篇 |
2001年 | 436篇 |
2000年 | 368篇 |
1999年 | 322篇 |
1998年 | 311篇 |
1997年 | 304篇 |
1996年 | 268篇 |
1995年 | 287篇 |
1994年 | 272篇 |
1993年 | 240篇 |
1992年 | 220篇 |
1991年 | 235篇 |
1990年 | 236篇 |
1989年 | 214篇 |
1988年 | 176篇 |
1987年 | 179篇 |
1986年 | 184篇 |
1985年 | 233篇 |
1984年 | 222篇 |
1983年 | 165篇 |
1982年 | 229篇 |
1981年 | 158篇 |
1980年 | 150篇 |
1979年 | 113篇 |
1978年 | 96篇 |
1977年 | 104篇 |
1976年 | 79篇 |
1975年 | 68篇 |
1974年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Transfusion and apheresis science》2022,61(4):103487
When the COVID-19 pandemic hit, blood transfusion services worldwide started collection of convalescent plasma as early as possible, as exemplified by the response in Norway. There were challenges related to donor selection, donor safety, testing for relevant antibodies and indications for and dosing of the convalescent plasma. As more knowledge became available, the product quality was more standardised. Multiple case reports, observational studies and some randomized studies were published during the pandemic, as well as laboratory studies reporting different approaches to antibody testing. The results were conflicting and the importance of convalescent plasma was disputed.Even though there has been strong international collaboration with involvement of many key organisations, we may better prepare for the next pandemic. An even stronger, more formalised collaboration between these organisations could provide more clear evidence of the importance of convalescent plasma, based on the principles of passive immunisation. 相似文献
2.
A Coupled FEM-BEM Approach for the Solution of the Free-Boundary Axi-Symmetric Plasma Equilibrium Problem 下载免费PDF全文
M. Bonotto D. Abate P. Bettini & F. Villone 《Communications In Computational Physics》2022,31(1):27-59
In this paper we present a coupled Finite Element Method – Boundary Element Method (FEM-BEM) approach for the solution of the free-boundary axi-symmetric
plasma equilibrium problem. The proposed method, obtained from an improvement
of the Hagenow-Lackner coupling method, allows to efficiently model the equilibrium
problem in unbounded domains by discretizing only the plasma region; the external
conductors can be modelled either as 2D or 3D models, according to the problem of interest. The paper explores different iterative methods for the solution of the nonlinear
Grad-Shafranov equation, such as Picard, Newton-Raphson and Newton-Krylov, in order to provide a robust and reliable tool, able to handle large-scale problems (e.g. high
resolution equilibria). This method has been implemented in the FRIDA code (FRee-boundary Integro-Differential Axisimmetric – https://github.
om/matteobonotto/
FRIDA), together with a suitable Adaptive Integration Technique (AIT) for the computation of the source term. FRIDA has been successfully tested and validated against
experimental data from RFX-mod device, and numerical equilibria of an ITER-like device. 相似文献
3.
Noreen M. Walsh Heinz Kutzner Luis Requena Lorenzo Cerroni 《Journal of cutaneous pathology》2019,46(9):698-708
We review the spectrum of cutaneous disorders associated with inflammatory and neoplastic plasmacytic pathology. Because plasma cells are derived from B‐lymphocytes our overview includes discussion of certain lymphoplasmacytic proliferations. It is structured along histopathological lines, addressing conditions characterized by (a) cutaneous plasma cell infiltrates, (b) deposits of plasma cell products or their derivatives in the skin and (c) miscellaneous, poorly understood cutaneous complications of plasmacytic disorders. Lesions arising primarily in the skin and those due to cutaneous involvement by multisystem disorders are addressed. The range includes a spectrum of tumefactive and circulatory manifestations. We highlight key clinical and pathological features of the different conditions and outline recent advances in our understanding of these entities. By emphasizing the dermatopathological characteristics of this spectrum of disorders we hope to hone the diagnostic accuracy of practitioners in the field. 相似文献
4.
5.
Pierre Tiberghien Xavier de Lamballerie Pascal Morel Pierre Gallian Karine Lacombe Yazdan Yazdanpanah 《Vox sanguinis》2020,115(6):488-494
Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the number of COVID-19 cases escalates steeply worldwide. Prior findings in various viral respiratory diseases including SARS-CoV-related pneumonia suggest that convalescent plasma can reduce mortality, although formal proof of efficacy is still lacking. By reducing viral spread early on, such an approach may possibly downplay subsequent immunopathology. Identifying, collecting, qualifying and preparing plasma from convalescent patients with adequate SARS-CoV-2-neutralizing Ab titres in an acute crisis setting may be challenging, although well within the remit of most blood establishments. Careful clinical evaluation should allow to quickly establish whether such passive immunotherapy, administered at early phases of the disease in patients at high risk of deleterious evolution, may reduce the frequency of patient deterioration, and thereby COVID-19 mortality. 相似文献
6.
7.
8.
9.
冯莹 《中国实用外科杂志》2020,40(5):531-536
易栓症是外科围手术期静脉血栓栓塞症(VTE)的防治重点。对于接受手术的止凝血障碍病人,需要谨慎评估VTE的个体风险,同时兼顾手术和麻醉的性质、出血障碍类型和严重程度、年龄、体重指数(BMI)、血栓形成史、恶性肿瘤和其他高危共患病。VTE风险应与已知出血障碍病人使用抗凝相关的出血风险平衡。实验室检查有助于发现和判断血栓与出血的病因,对病人的止凝血代偿能力作出评估,并对抗凝药物的合理使用提供依据。对上述病人,建议术后不常规使用药物预防血栓,尤其是血友病病人,但围手术期因子替代和止血药物的过度应用仍存在导致血栓的风险。使用低分子肝素(LMWH)和直接口服抗凝剂前应评估肾小球滤过率。当血小板计数<50×109/L,LMWH短期减量应用可能相对安全,监测抗Хa水平可用于调整中重度血小板减少症病人LMWH的剂量。主要消化道出血停止和重新使用华法林应至少相隔7 d。对于高血栓栓塞风险和术后高出血风险病人,术后当晚和术后第1天减量应用直接口服抗凝剂是一种可取的做法。 相似文献
10.